Aeolus Pharmaceuticals Inc. announced consolidated earnings results for the fourth quarter and full year ended September 30, 2012. For the quarter, the company reported contract revenue of $1,399,000 against $2,124,000 a year ago. Loss from operations was $497,000 against $1,008,000 a year ago. Net loss was $7,106,000 or $0.11 per basic and diluted share against $2,149,000 or $0.04 per basic and diluted share a year ago.

For the year, the company reported contract revenue of $7,293,000 against $4,821,000 a year ago. Loss from operations was $2,371,000 against $3,902,000 a year ago. Net income was $1,698,000 or $0.02 per basic and diluted share against $299,000 or $0.00 per basic and diluted share a year ago.